CLINICAL_TRIALS
trial_result
· 2021-03-25
Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer [Phase 3]
Summary
Phase 3 trial update evaluating the safety and efficacy of relugolix in men with advanced prostate cancer has completed and results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Myovant Sciences GmbH | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2021-03-25